Close

Peregrine Pharmaceuticals (PPHM) Tops Q3 EPS by 3c

March 12, 2013 4:06 PM EDT
Peregrine Pharmaceuticals (NASDAQ: PPHM) reported Q3 EPS of ($0.04), $0.03 better than the analyst estimate of ($0.07).

For earnings history and earnings-related data on Peregrine Pharmaceuticals (PPHM) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings